Trial · NCT07905963
Bioimpedance and Multiparametric Ultrasound-Guided Fluid Management After Kidney Transplantation
NCT07905963, Not applicable, Not yet recruiting, Hospital Universitario Ramon y Cajal
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Bioimpedance and Multiparametric Ultrasound-Guided Fluid Management After Kidney Transplantation. Trials, record NCT07905963. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07905963
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Bioimpedance and Multiparametric Ultrasound-Guided Fluid Management After Kidney Transplantation
- NCT number
- NCT07905963
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 650 participants, estimated
- Lead sponsor
- Hospital Universitario Ramon y Cajal
- Conditions
- Kidney Transplantation, Delayed Graft Function, Fluid Overload
- Interventions
- Multiparametric assessment, Structured usual care
- First posted
- 2026-10-30
- Last updated
- 2026-11-12
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Hierarchical composite of death, graft loss, sustained dialysis and eGFR (win ratio) | Day 30 post-transplant (dialysis assessed up to day 7; eGFR measured on days 28-35) | Each intervention participant is compared with each control participant within strata (centre, donor type), moving to the next level only if tied: (1) all-cause death (earlier is worse); (2) graft loss, defined as permanent return to dialysis or transplantectomy (earlier is worse); (3) sustained dialysis within 7 days after reperfusion, excluding a single session in the first 24 h for isolated hyperkalaemia (more sessions is worse); (4) eGFR at 1 month, CKD-EPI 2021 creatinine equation (higher is better). Reported as stratified win ratio with 95% CI (Finkelstein-Schoenfeld test), win odds and net benefit. |
| Secondary | Delayed graft function, by dialysis and functional (CRR2) definitions | Day 2 (CRR2) and up to day 7 post-transplant (dialysis) | Proportion of participants requiring any dialysis within the first 7 days after transplantation, and proportion with a creatinine reduction ratio on day 2 below 30%. |
| Secondary | Number of dialysis sessions | Up to day 7 post-transplant | Number of dialysis sessions and days to last dialysis within the first 7 days. |
| Secondary | Length of stay | Up to 90 days post-transplant | Days from transplantation to discharge from the index admission, analysed with death as a competing event. |
| Secondary | Days alive and out of hospital at 30 days | Day 30 post-transplant | Number of days alive and out of hospital within the first 30 days after transplantation. |
| Secondary | Acute pulmonary oedema | Up to day 30 post-transplant | Proportion of participants with acute pulmonary oedema, adjudicated by a blinded committee using clinical, radiological and oxygenation criteria. |
| Secondary | Cardiovascular events | Up to day 30 post-transplant | Proportion of participants with arrhythmia, acute coronary syndrome, heart failure, stroke, arterial or venous thrombosis, or major bleeding. |
| Secondary | 30-day readmission | Up to 30 days after discharge from the index admission | Proportion of participants readmitted after discharge from the index admission, by cause. |
| Secondary | BIA overhydration trajectory | Pre-transplant (0-24 h before surgery), days 1, 3 and 7, pre-discharge and month 1 post-transplant | Absolute overhydration (L) measured by bioimpedance spectroscopy at each assessment. |
| Secondary | eGFR at 3 and 12 months | Month 3 and month 12 post-transplant | Estimated glomerular filtration rate (CKD-EPI 2021 creatinine equation, mL/min/1.73 m²) obtained from medical records. |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers20
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07905963
GET https://conductscience.org/api/trials/v1/NCT07905963/registered